Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perindopril pilot study in moderate- and high-risk hypertrophic cardiomyopathy
2015-004317-24Phase 2Terminated
- Sponsor
- Azienda Ospedaliero-Universitaria Careggi
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of perindopril in hypertrophic cardiomyopathy (HCM), sponsored by Azienda Ospedaliero-Universitaria Careggi. Primary endpoint: Change in post-vasodilatation global myocardial blood flow. Started Sep 2021; status: terminated.
02
Drugs
perindopril
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on 2015-004317-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004317-24.